222 related articles for article (PubMed ID: 18682687)
21. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
[TBL] [Abstract][Full Text] [Related]
22. AK-1, a SIRT2 inhibitor, destabilizes HIF-1α and diminishes its transcriptional activity during hypoxia.
Lee SD; Kim W; Jeong JW; Park JW; Kim JE
Cancer Lett; 2016 Apr; 373(1):138-145. PubMed ID: 26808575
[TBL] [Abstract][Full Text] [Related]
23. EF24 induces ferroptosis in osteosarcoma cells through HMOX1.
Lin H; Chen X; Zhang C; Yang T; Deng Z; Song Y; Huang L; Li F; Li Q; Lin S; Jin D
Biomed Pharmacother; 2021 Apr; 136():111202. PubMed ID: 33453607
[TBL] [Abstract][Full Text] [Related]
24. Effects of Curcumin Analogues DMC and EF24 in Combination with the Cytokine TRAIL against Kidney Cancer.
Ibáñez Gaspar V; McCaul J; Cassidy H; Slattery C; McMorrow T
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684883
[TBL] [Abstract][Full Text] [Related]
25. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1.
Bae MK; Kim SH; Jeong JW; Lee YM; Kim HS; Kim SR; Yun I; Bae SK; Kim KW
Oncol Rep; 2006 Jun; 15(6):1557-62. PubMed ID: 16685395
[TBL] [Abstract][Full Text] [Related]
26. EF24 (a Curcumin Analog) and ZSTK474 Emphasize the Effect of Cabozantinib in Medullary Thyroid Cancer.
Bertazza L; Sensi F; Cavedon E; Watutantrige-Fernando S; Censi S; Manso J; Vianello F; Casal Ide E; Iacobone M; Pezzani R; Mian C; Barollo S
Endocrinology; 2018 Jun; 159(6):2348-2360. PubMed ID: 29688429
[TBL] [Abstract][Full Text] [Related]
27. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis.
Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA
Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286
[TBL] [Abstract][Full Text] [Related]
28. EF24 Suppresses Invasion and Migration of Hepatocellular Carcinoma Cells
Zhao R; Tin L; Zhang Y; Wu Y; Jin Y; Jin X; Zhang F; Li X
Biomed Res Int; 2016; 2016():8569684. PubMed ID: 27999817
[TBL] [Abstract][Full Text] [Related]
29. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.
Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J
Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553
[TBL] [Abstract][Full Text] [Related]
30. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression.
Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P
J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of novel
Xie X; Tu J; You H; Hu B
Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Zhang D; Wang Y; Dong L; Huang Y; Yuan J; Ben W; Yang Y; Ning N; Lu M; Guan Y
Cancer Sci; 2013 Dec; 104(12):1690-6. PubMed ID: 24112101
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.
Kong X; Lin Z; Liang D; Fath D; Sang N; Caro J
Mol Cell Biol; 2006 Mar; 26(6):2019-28. PubMed ID: 16507982
[TBL] [Abstract][Full Text] [Related]
34. Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24.
Rao G; Houson H; Nkepang G; Yari H; Teng C; Awasthi V
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G318-G327. PubMed ID: 29746173
[TBL] [Abstract][Full Text] [Related]
35. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.
Flügel D; Görlach A; Michiels C; Kietzmann T
Mol Cell Biol; 2007 May; 27(9):3253-65. PubMed ID: 17325032
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.
Cho IR; Koh SS; Min HJ; Park EH; Ratakorn S; Jhun BH; Jeong SH; Yoo YH; Youn HD; Johnston RN; Chung YH
Cancer Gene Ther; 2010 May; 17(5):365-72. PubMed ID: 20075985
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells.
Awasthi V; Vilekar P; Rao G; Awasthi S
Immunobiology; 2020 Mar; 225(2):151886. PubMed ID: 31812341
[TBL] [Abstract][Full Text] [Related]
39. Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53.
Abd-Aziz N; Stanbridge EJ; Shafee N
J Gen Virol; 2016 Dec; 97(12):3174-3182. PubMed ID: 27902314
[TBL] [Abstract][Full Text] [Related]
40. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.
Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G
Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
